Welcome to CDC stacks | Ciprofloxacin for post-exposure prophylaxis of anthrax : emergency use instructions for healthcare providers - 56838 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Ciprofloxacin for post-exposure prophylaxis of anthrax : emergency use instructions for healthcare providers
  • Published Date:
    08/18/2017
  • Language:
    English
Filetype[PDF-183.85 KB]


Details:
  • Description:
    This fact sheet provides instructions for the use of ciprofloxacin for post‐exposure prophylaxis (PEP) during an emergency involving anthrax (referred to as Emergency Use Instructions (EUI) fact sheet). Ciprofloxacin is FDA‐approved for PEP of inhalation anthrax – to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis (B. anthracis). The Food and Drug Administration (FDA) has also issued an order permitting the emergency dispensing of oral formulations of ciprofloxacin without a prescription during an anthrax emergency to individuals who may have been exposed to B. anthracis.

    Ciprofloxacin EUI for Healthcare Providers (originally issued 03/28/2016; revised 08/18/2017)

    cipro-eui-hcp-H.pdf

  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
You May Also Like: